- Home
- HQ vs CYRX Comparison
HQ vs CYRX Comparison
Compare HQ & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQ | CYRX |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | Singapore | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.7M | 814.9M |
| IPO Year | 2025 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HQ | CYRX |
|---|---|---|
| Price | $16.08 | $16.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $20.50 | $19.67 |
| AVG Volume (30 Days) | 440.5K | ★ 630.2K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $10.96 |
| Revenue Next Year | N/A | $9.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.29 | $7.61 |
| 52 Week High | $45.00 | $18.36 |
Technical Indicators
Market Signals| Indicator | HQ | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.95 | 49.50 |
| Support Level | $13.68 | $14.55 |
| Resistance Level | $16.37 | $17.98 |
| Average True Range (ATR) | 1.22 | 0.59 |
| MACD | 0.18 | -0.09 |
| Stochastic Oscillator | 57.54 | 19.72 |
Price Performance
Historical ComparisonAbout HQ Horizon Quantum Holdings Ltd. Class A Ordinary Shares
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.